Search

everythinglearnresearchcommunity

for

Search:↓

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Low selenium intake may delay puberty in boys but not in girls.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Finasteride use is strongly linked to sexual dysfunction, especially in young men treating hair loss.

Alopecia areata patients have a higher risk of other immune-related diseases.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.

African American adults and non-White children experience more hair loss episodes than White patients with alopecia areata.

Finasteride may cause depression and suicidal thoughts, especially in young men.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Alopecia treatments are costly and often not covered by insurance, causing financial stress.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

Using microneedling with platelet-rich plasma is more effective and just as safe as microneedling alone for treating acne scars.

Alopecia areata is linked to PTSD, alcohol use, anxiety, and depression.

No single treatment is clearly effective for central serous chorioretinopathy.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Vaccination reduces COVID-19 severity, and some symptoms like hair loss can persist for a year.

Serenoa repens is mostly safe but has some risks, especially at high doses or when used with other products for over two weeks.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Women are more likely to have long-term post-COVID symptoms than men.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Exercising women should be screened for anemia due to its prevalence and impact on performance.

Alopecia areata greatly affects people's life quality, mental health, and work life.

"Alpenta" effectively reduces hair loss and improves hair growth in women with telogen effluvium.

Tripterygium wilfordii Hook F often causes side effects like stomach issues and skin reactions.

Finasteride use linked to increased suicidality in patients under 45.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Biologics for severe asthma have known side effects, but some new risks need more study.

Older age and existing health conditions increase COVID-19 death risk.